SP3 and neoplasm: The results showed that a single CpG site at −155 bp, located at the junction of the two Sp1/Sp3 binding sites, was more significantly methylated in tumor tissues (40.4% and 9.0%, respectively), in which CMTM3 was down-regulated, than in corresponding non-tumor tissues (Figure 5B).